Antibody fragment prevents hemorrhages associated with new Alzheimer's treatments

Antibody fragment prevents hemorrhages associated with new Alzheimer's treatments

In 2025, the European Medicines Agency approved two antibodies for Alzheimer’s disease: lecanemab (LeqembiTM, from Biogen) and donanemab (Kisunla, from Eli Lilly and Co.), both based on immunotherapy (the use of molecules from the immune system to treat diseases). These antibodies, obtained in the laboratory, act against the Aβ peptide, a protein fragment that accumulates…

Read More
Crypto Biz: Nobody told Saylor ‘never sell’

Crypto Biz: Nobody told Saylor ‘never sell’

Strategy’s Bitcoin sale challenged the “never sell” narrative, while JPMorgan attacked CLARITY and Capital B pursued a huge fundraising plan for BTC. Strategy’s sale of 32 Bitcoin shouldn’t have mattered. The company still holds hundreds of thousands of BTC, and the transaction barely moved the needle on its balance sheet. Yet the market reaction was…

Read More